We are live on ! Find out more
NERV icon

Minerva Neurosciences
NERV

63 hedge funds and large institutions have $225M invested in Minerva Neurosciences in 2016 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

583% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 6

220% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 5

197% more capital invested

Capital invested by funds: $75.6M → $225M (+$149M)

125% more funds holding

Funds holding: 28 → 63 (+35)

Holders
63
Holders Change
+35
Holders Change %
+125%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
41
Increased
16
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$17.6M
2
CAM
Cormorant Asset Management
Massachusetts
+$8.32M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$7.95M
4
Franklin Resources
Franklin Resources
California
+$6.76M
5
Millennium Management
Millennium Management
New York
+$6.41M

Top Sellers

Rank Fund Capital Flow
1
DADC
D.A. Davidson & Co
Montana
-$819K
2
UBS Group
UBS Group
Switzerland
-$290K
3
Goldman Sachs
Goldman Sachs
New York
-$275K
4
HCMT
Highland Capital Management (Texas)
Texas
-$165K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
1
Federated Hermes
Pennsylvania
$61.9M +$7.95M +125,000 +20%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$50.9M +$17.6M +276,859 +80%
CAM
3
Cormorant Asset Management
Massachusetts
$28.6M +$8.32M +130,882 +60%
HCMT
4
Highland Capital Management (Texas)
Texas
$8.87M -$165K -2,592 -2%
Franklin Resources
5
Franklin Resources
California
$8.68M +$6.76M +106,250 New
Millennium Management
6
Millennium Management
New York
$8.48M +$6.41M +100,803 +3,338%
PA
7
Perceptive Advisors
New York
$8.28M – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$6.17M +$666K +10,483 +16%
BBA
9
Baker Bros. Advisors
New York
$5.19M +$4.04M +63,551 New
BFA
10
BlackRock Fund Advisors
California
$4.22M +$3.08M +48,464 +1,497%
O
11
OrbiMed
New York
$3.28M +$2.56M +40,188 New
Marshall Wace
12
Marshall Wace
United Kingdom
$2.67M +$2.08M +32,688 New
State Street
13
State Street
Massachusetts
$2.48M +$1.94M +30,435 New
Renaissance Technologies
14
Renaissance Technologies
New York
$2.06M +$1.37M +21,525 +586%
VC
15
Vivo Capital
California
$2.04M +$1.59M +25,000 New
EI
16
EAM Investors
California
$2.01M +$1.57M +24,628 New
Northern Trust
17
Northern Trust
Illinois
$1.82M +$1.42M +22,314 New
BCM
18
Bridgeway Capital Management
Texas
$1.74M +$633K +9,950 +87%
BIT
19
BlackRock Institutional Trust
California
$1.37M +$1.07M +16,757 New
IHM
20
Iguana Healthcare Management
New York
$1.28M +$993K +15,625 New
NC
21
Nexthera Capital
New York
$1.09M +$579K +9,112 +214%
JGC
22
J. Goldman & Co
New York
$1.03M +$802K +12,617 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$1.02M +$512K +8,049 +182%
DCM
24
DAFNA Capital Management
California
$818K +$637K +10,013 New
EA
25
Emerald Acquisition
Washington
$642K +$500K +7,864 New
1
2 3

NERV Hedge Fund Activity: Q2 2016 in Review

63 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q2 2016, worth a combined $225M — up 197% from $75.6M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new NERV positions and 6 closed out — a net gain of 35 holders — while 16 added to existing stakes and 5 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $17.6M. The largest seller was D.A. Davidson & Co, exiting entirely with an estimated $819K sold.

  • 63 institutional investors held Minerva Neurosciences (NERV) as of Q2 2016, up from 28 in Q1 2016.
  • Funds reported $225M of Minerva Neurosciences stock for Q2 2016, up 197% quarter-over-quarter.
  • 41 funds opened new Minerva Neurosciences positions in Q2 2016 and 6 closed out, a net change of +35 holders.
  • The largest Minerva Neurosciences buyer in Q2 2016 was Fidelity Investments, an estimated $17.6M added.
  • The largest Minerva Neurosciences seller in Q2 2016 was D.A. Davidson & Co, an estimated $819K sold.

Based on aggregated 13F filings for Q2 2016.